Learning from product labels and label changes: how to build pharmacogenomics into drug-development programs.
about
Chapter 7: PharmacogenomicsAn inter-professional approach to personalized medicine education: one institution's experiencePharmacogenomics in early-phase clinical developmentScientific challenges and implementation barriers to translation of pharmacogenomics in clinical practice.Implications of pharmacogenetics for the therapeutic use of antiepileptic drugs.Polymorphism in CYP2D6 and CYP2C19, members of the cytochrome P450 mixed-function oxidase system, in the metabolism of psychotropic drugs.Pharmacogenomic information in FDA-approved drug labels: Application to pediatric patients.Health regulatory communications of well-established safety-related pharmacogenomics associations in six developed countries: an evaluation of alignment.A question-based approach to adopting pharmacogenetics to understand risk for clinical variability in pharmacokinetics in early drug development.Generating and weighing evidence in drug development and regulatory decision making: 5th US FDA-DIA workshop on pharmacogenomics.
P2860
Q21563496-75C9C50A-D7DB-48ED-8CD1-A857764C1DB3Q33565033-662240B6-2C4E-40CC-B2D7-F955CF09A688Q36001208-19903C38-6FD1-481D-B919-58A3C8AD1651Q36702588-CD2E6807-F8E4-4D5C-9E03-2D2ABBB7FBC4Q38181565-1B3E8271-22BD-4834-BC94-C17BC3D93CB5Q38258243-3C85A6A0-3253-460D-B28C-2C57EA00FF72Q40181637-E39B897A-5F42-4364-8A21-7E797011B9CDQ48861311-B187633A-9D26-4C25-BE14-5842569A0380Q51052693-0BD25A89-0097-468C-BC09-5BA963AB3EBFQ51893884-4E3C5BB5-3B41-46AE-9D5C-55BCA644A3DE
P2860
Learning from product labels and label changes: how to build pharmacogenomics into drug-development programs.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Learning from product labels a ...... nto drug-development programs.
@en
Learning from product labels a ...... nto drug-development programs.
@nl
type
label
Learning from product labels a ...... nto drug-development programs.
@en
Learning from product labels a ...... nto drug-development programs.
@nl
prefLabel
Learning from product labels a ...... nto drug-development programs.
@en
Learning from product labels a ...... nto drug-development programs.
@nl
P2093
P2860
P356
P1433
P1476
Learning from product labels a ...... nto drug-development programs.
@en
P2093
Arlene R Hughes
Bryan Dechairo
Issam Zineh
Lawrence J Lesko
Linda C Surh
Marisa Papaluca-Amati
Michael A Pacanowski
Michael Mosteller
Myong-Jin Kim
Nadine A Cohen
P2860
P304
P356
10.2217/PGS.10.138
P577
2010-12-01T00:00:00Z